FSD Pharma Inc C.HUGE

Alternate Symbol(s): HUGE

Healthcare Cannabis

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.

CSE:HUGE - Post by User

FSD Pharma Inc > hmmmmm

<< Previous

Bullboard Posts

Next >>

Comment by Chuckie18on Mar 10, 2021 12:34am

37 Views

Post# 32760142

RE:hmmmmm

1 Wall Street analysts have issued ratings and price targets for FSD Pharma in the last 12 months. Their average twelve-month price target is $11.00, predicting that the stock has a possible upside of 397.74%. The high price target for HUGE is $11.00 and the low price target for HUGE is $11.00. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."

<< Previous

Bullboard Posts

Next >>

Optimi Health makes commercial entry into Australia